| 1. | 20forMSFT | |
| 2. | vstarknox | |
| 3. | JasonJohnJacobs | |
| 4. | cogvos6 | |
| 5. | sspd94 |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | JasonJohnJacobs 03/11/2018 4 sure |
| 2. | JasonJohnJacobs 01/22/2018 Downgrade not hurting us at all |
| 3. | JasonJohnJacobs 08/03/2018 Beats EPS loss estimates by $0.01 |
| 4. | JasonJohnJacobs 10/18/2017 Panic in the streets |
| 5. | JasonJohnJacobs 08/27/2018 Esperion Announces Positive Top-Line Results from Pivotal Phase 3 Bempedoic Acid / Ezetimibe Combination Pill Study |
| 6. | 20forMSFT 06/13/2018 Esperion Announces Late-Breaking Oral Presentation of Full Study 4 Results (1002-048) at the International Symposium on Atherosclerosis |
| 7. | vstarknox 03/11/2018 WOW! |
| 8. | vstarknox 03/27/2018 Esperion Announces Positive Top-Line Results from Phase 2 Study of Bempedoic Acid Added-On to a PCSK9 Inhibitor in Patients with Hypercholesterolemia |
| 9. | 20forMSFT 10/18/2017 Thought company said today would be a big day? |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Esperion Therapeutics, Inc.
- ESPR
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.